KEMRI UNVEILS LANDMARK REPORT LINKING VACCINES TO FIGHT AGAINST ANTIMICROBIAL RESISTANCE IN KENYA.
BY NJOKI KARANJA Nairobi, March 27, 2026. The Kenya Medical Research Institute (KEMRI) has unveiled a groundbreaking policy brief and report highlighting the critical role of vaccines in combating antimicrobial resistance (AMR), a growing public health threat in Kenya and across Africa. The report, titled “The Value of Vaccines to Address Antimicrobial Resistance in Kenya,” was launched at the Mövenpick Hotel in Nairobi during a high-level event attended by government officials, researchers, development partners, and members of the press. Speaking during the unveiling, KEMRI Acting Director General and CEO Prof. Elijah Songok warned that antimicrobial resistance is no longer a distant concern but a present and escalating crisis. He described AMR as a “silent pandemic” that is already claiming lives, complicating routine medical procedures, and placing a heavy burden on healthcare systems. The initiative, jointly developed by KEMRI and the One Health Trust, brought toge...